Switching to Biosimilars for RA, Part Two: My Experience as an ‘Outlier’ Trying (So Far) 3 Biosimilars
In April 2023, I received a letter from the Ontario government with information about the new biosimilar switching policy. I had until the end of the year to switch from the biologic medication I take to treat my rheumatoid arthritis (RA) to a biosimilar. I did my best to be hopeful and believe it would…
You May Have to Switch to a Biosimilar for Rheumatoid Arthritis. Here’s Why.
In March 2023, I received a letter from the Ontario government. It informed me that a biosimilar switching policy was now in place. People like me who receive funding from the government to pay for Biologics for rheumatoid arthritis (RA), Crohn’s disease, and other forms of autoimmune disease were given until the end of 2023…